[go: up one dir, main page]

MX2019003751A - Proteina terapeutica. - Google Patents

Proteina terapeutica.

Info

Publication number
MX2019003751A
MX2019003751A MX2019003751A MX2019003751A MX2019003751A MX 2019003751 A MX2019003751 A MX 2019003751A MX 2019003751 A MX2019003751 A MX 2019003751A MX 2019003751 A MX2019003751 A MX 2019003751A MX 2019003751 A MX2019003751 A MX 2019003751A
Authority
MX
Mexico
Prior art keywords
therapeutic protein
therapy
deflamin
nutraceutical
cancer
Prior art date
Application number
MX2019003751A
Other languages
English (en)
Inventor
Isabel Gusmão Lima Ana
Patricia Mota Guerreiro Joana
Manuel De Seixas Boavida Ferreira Ricardo
Original Assignee
Inst Superior Agronomia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1616715.7A external-priority patent/GB201616715D0/en
Priority claimed from PT109645A external-priority patent/PT109645A/pt
Application filed by Inst Superior Agronomia filed Critical Inst Superior Agronomia
Publication of MX2019003751A publication Critical patent/MX2019003751A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/31—Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Una composición de polipéptido de deflamina para uso en un método de tratamiento del cuerpo humano o animal mediante terapia en donde la terapia preferiblemente previene o trata la inflamación o el cáncer, o proporciona un nutracéutico.
MX2019003751A 2016-09-30 2017-10-02 Proteina terapeutica. MX2019003751A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1616715.7A GB201616715D0 (en) 2016-09-30 2016-09-30 Therapeutic protein
PT109645A PT109645A (pt) 2016-09-30 2016-09-30 Composição de polipéptidos da deflamina, sua utilização num método de tratamento e sua preparação, vetores de ácido nucleico que a expressam e anticorpo para aqueles polipéptidos
PCT/EP2017/075020 WO2018060528A2 (en) 2016-09-30 2017-10-02 Therapeutic protein

Publications (1)

Publication Number Publication Date
MX2019003751A true MX2019003751A (es) 2019-12-16

Family

ID=60582543

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019003751A MX2019003751A (es) 2016-09-30 2017-10-02 Proteina terapeutica.

Country Status (14)

Country Link
US (1) US20200113969A1 (es)
EP (1) EP3518957B1 (es)
JP (1) JP7510255B2 (es)
KR (1) KR20190061015A (es)
CN (1) CN110214017B (es)
AU (1) AU2017334047B2 (es)
BR (1) BR112019006174A2 (es)
CA (1) CA3037800A1 (es)
CL (1) CL2019000846A1 (es)
CO (1) CO2019003865A2 (es)
IL (1) IL265708A (es)
MX (1) MX2019003751A (es)
WO (1) WO2018060528A2 (es)
ZA (1) ZA201902689B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7304053B2 (ja) * 2019-02-15 2023-07-06 国立大学法人金沢大学 肝臓がん発症リスクの判定方法、及び肝臓がん発症リスクの判定キット
CN112753943A (zh) * 2021-01-27 2021-05-07 上海理工大学 一种具有炎症性肠病调节功能的能量棒及其制作方法
CN112772843A (zh) * 2021-01-27 2021-05-11 上海理工大学 一种适用于ibd炎症性肠病患者食用的代餐粉及其制备方法
CN114106083A (zh) * 2021-12-09 2022-03-01 南开大学 一种小米蛋白和小米蛋白水解物的制备方法及小米蛋白水解物的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20041308A1 (it) * 2004-06-29 2004-09-29 Fraunhofer Ges Zur Foerderung... Processo per la purificazione da seme di lupiom di frazioni proteiche attive sul metabolismo lipidico
DK2333086T3 (en) * 2005-07-21 2015-04-07 Inst Superior Agronomia Use of a lupinus protein
WO2008144939A1 (en) * 2007-06-01 2008-12-04 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food A process of aqueous protein extraction from brassicaceae oilseeds
US8609161B2 (en) * 2008-05-30 2013-12-17 Ospedale San Raffaele S.R.L. Conglutin-gamma as medicament and diet supplement
CA2814428C (en) * 2010-10-12 2018-04-10 Consumo Em Verde - Biotecnologia Das Plantas, S.A. Antimicrobial protein

Also Published As

Publication number Publication date
IL265708A (en) 2019-05-30
CO2019003865A2 (es) 2019-04-30
WO2018060528A3 (en) 2018-07-05
AU2017334047B2 (en) 2025-01-23
JP7510255B2 (ja) 2024-07-03
CN110214017B (zh) 2024-07-23
EP3518957A2 (en) 2019-08-07
CL2019000846A1 (es) 2019-11-15
WO2018060528A2 (en) 2018-04-05
EP3518957C0 (en) 2024-05-15
CN110214017A (zh) 2019-09-06
US20200113969A1 (en) 2020-04-16
ZA201902689B (en) 2019-11-27
KR20190061015A (ko) 2019-06-04
EP3518957B1 (en) 2024-05-15
CA3037800A1 (en) 2018-04-05
BR112019006174A2 (pt) 2019-06-18
JP2020503060A (ja) 2020-01-30
AU2017334047A1 (en) 2019-05-16

Similar Documents

Publication Publication Date Title
MX2020008906A (es) Compuestos con actividad inductora de ferroptosis y métodos de uso de estos.
MX2022010270A (es) Nuevo enfoque para tratar el cancer mediante el uso de la inmunomodulacion.
MX2020008680A (es) Terapia de combinacion con apilimod y agentes glutamatergicos.
WO2016025635A3 (en) Combination therapy for treating cancer
BR112018013731A2 (pt) combinações anti-egfr para o tratamento de tumores
MX2022008868A (es) Tratamiento del cancer con tg02.
GEP20217317B (en) Combination therapy for the treatment of cancer
MX2017006938A (es) Terapia de combinacion para el tratamiento de cancer.
MX2018010223A (es) Terapia combinada para tratamiento de cancer de ovario.
PH12017500392A1 (en) Medical treatments based on anamorelin
MX2020001727A (es) Terapia de combinacion.
MX379201B (es) Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
IL279277A (en) In vivo controlled combination therapy for treatment of cancer
MX2019003751A (es) Proteina terapeutica.
HK1250626A1 (zh) 借助塞里班土单抗的组合治疗
MX2018009499A (es) Anticuerpos monoclonales especificos de egfl6 y metodos de su uso.
MY186840A (en) Method for treating psoriasis patient which received anti-tnf-alpha antibody therapy
BR112016023011A2 (pt) tratamento de câncer gástrico
ZA202002107B (en) Use of specific sirna against protein s for the treatment of hemophilia
JOP20200124A1 (ar) طُرق لعلاج سرطان المثانة باستخدام جيمسيتابين وعلاج مدوامة لذلك
MX2020008881A (es) Métodos de tratamiento contra el cáncer que comprenden inhibidores de chk1.
MX2017013666A (es) Terapia de combinacion de agente anti-fuctactico y agente de inmunoterapia y composiciones para el tratamiento de cancer.
HK1259026A1 (zh) 用於治疗癌症的抗趋除剂的局部递送
WO2018231799A8 (en) Methods of treating brain tumors using combination therapy
MX2017013668A (es) Terapia de combinacion de agente anti-fuctactico y agente anti-cancer y composiciones para el tratamiento de cancer.